BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Transient receptor potential cation channel subfamily V member 1' and Ligand = 'BDBM142731'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Transient receptor potential cation channel subfamily V member 1


(Homo sapiens (Human))
BDBM142731
PNG
(US8937092, 84)
Show SMILES Cc1cccc(c1)-c1nc(ccc1CNC(=O)Nc1ccc(CNS(N)(=O)=O)cc1)C(F)(F)F
Show InChI InChI=1S/C22H22F3N5O3S/c1-14-3-2-4-16(11-14)20-17(7-10-19(30-20)22(23,24)25)13-27-21(31)29-18-8-5-15(6-9-18)12-28-34(26,32)33/h2-11,28H,12-13H2,1H3,(H2,26,32,33)(H2,27,29,31)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
9n/an/an/an/an/an/an/an/a



Gruenenthal GmbH

US Patent


Assay Description
The FLIPR protocol consists of 2 substance additions. First the compounds to be tested (10 uM) are pipetted onto the cells and the Ca2+ influx is com...


US Patent US8937092 (2015)


BindingDB Entry DOI: 10.7270/Q27S7MG3
More data for this
Ligand-Target Pair